Price
No data yet.
Social Signal Score
Revenue
$105.60M-98.27%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Ugur Sahin
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7,807
- Beta
- 1.28
- Country
- DE
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 6.48
Financials
Revenue
$105.60M-98.3%Net Income
$-820.80M-125.6%EBITDA
$-584.70M-112.5%Free Cash Flow
$-44.80M-103.1%EPS (diluted)
$-3.24-126.2%Shares Outstanding (diluted)
253.33M-2.6%Operating Expenses
$748.80MCash & Debt
$9.74BReturn of Capital
$132.08MRevenue by Segment (annual)
$261.60MDividend per Share
$2.11Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.76B | $-1.09B | $-4.51 |
| 2024 | $2.75B | $-665.30M | $-2.77 |
| 2023 | $3.82B | $930.30M | $3.87 |
| 2022 | $17.31B | $9.43B | $38.08 |
| 2021 | $18.98B | $10.29B | $43.87 |
| 2020 | $482.30M | $15.20M | $0.06 |
| 2019 | $108.60M | $-179.10M | $-0.85 |
| 2018 | $127.58M | $-48.02M | $-0.21 |
| 2017 | $61.60M | $-85.65M | $-0.38 |
Valuation
BNTXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsbenzinga.com·5h ago·Neutral
Why Is BioNTech Stock Surging on Wednesday? BioNTech SE (NASDAQ:BNTX) stock is trading higher on Wednesday. Investors are probably reacting to Merck & Co Inc. (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) topline data from individualized cancer therapy for advanced skin cancer.
View source ↗
Earnings
Tue, Nov 3(in 3 months)
Consensus estimate $0.86 per share
Typical surprise +26.5% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$-3.70 vs $-2.40miss
- Tue, May 5$-2.43 vs $-2.54beat
- Tue, Mar 10$-1.44 vs $-0.22miss
- Mon, Nov 3$-0.14 vs $-1.12beat
- Mon, Aug 4$-1.82 vs $-2.69beat
- Mon, May 5$-1.82 vs $-2.48beat
Estimates and results for BNTX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BNTX officers and directors.
- Bought
- —
- Sold
- $5.5m
0 trades
1 trade
- Poetting Sierksold
49 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.